In one study, there was a sharp increase in Ki‐67 that was associated with TP53 mutations and focally NEC‐like histological transformation in 22% of patients with NET G3 followed for a median of 29 months. This evidence concerns the gene MKI67 and neuroendocrine carcinoma.